A randomized, open-label, multicenter, comparative study of therapeutic efficacy, safety and tolerability of BNO 1030 extract, containing marshmallow root, chamomile flowers, horsetail herb, walnut leaves, yarrow herb, oak bark, dandelion herb in the treatment of acute non-bacterial tonsillitis in children aged 6 to 18 years

This publication has 10 references indexed in Scilit:

• Effectiveness and tolerability of Tonsilgon® N in the treatment of recurrent upper respiratory tract infections in children: a non-interventional study in Russia
  Clinical Phytoscience, 2016
• Integrative management of pediatric tonsillopharyngitis: An international survey
  Complementary Therapies in Clinical Practice, 2016
• The global threat of antimicrobial resistance: science for intervention
  New Microbes and New Infections, 2015
• A review on the mechanism of sore throat in tonsillitis
  The Journal of Laryngology & Otology, 2013
• Suppression of interleukin (IL)-8 and human beta defensin-2 secretion in LPS-and/or IL-1β-stimulated airway epithelial A549 cells by a herbal formulation against respiratory infections (BNO 1030)
  Journal of Ethnopharmacology, 2011
• Imupret modulates the innate and adaptive immune system parameters in vitro
  Planta Medica, 2009
• Paracetamol and ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial
  Health Technology Assessment, 2009
• Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial
  BMJ, 2008
• Are Sore Throat Patients Who Hope for Antibiotics Actually Asking for Pain Relief?
  The Annals of Family Medicine, 2006
• Recommendations for reporting randomized controlled trials of herbal interventions: explanation and elaboration
  Journal of Clinical Epidemiology, 2006